Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 304
Selected: 0
NCT IDTitle
NCT00582244Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial
NCT02672189Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms
NCT03819829Blood Sampling of Healthy Volunteers for Immunological Research
NCT04574427INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue
NCT03223727Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223
NCT03305965The Effectiveness of Patient Navigation in Cancer Care
NCT02227082Olaparib and Radiotherapy in Inoperable Breast Cancer
NCT01024582Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer
NCT04133948Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma
NCT06279130Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations
NCT06329648Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer
NCT03048474Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
NCT02836548HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
NCT04330430Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (Stage IIIB/C/D-IV M1a) Melanoma With Injectable Disease
NCT02276430TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
NCT05406674Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer
NCT02091765RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT04998474FRAME-001 Personalized Vaccine in NSCLC
NCT02575066Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients
NCT01562431The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics
NCT04737382Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.
NCT06364631CARE1 Pragmatic Clinical Trial
NCT06634173The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer
NCT02938273Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)
NCT02485626Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors
NCT02934126The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer
NCT00426257Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
NCT03540420Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
NCT06237920Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
NCT00448266Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
NCT04813965Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms
NCT03295565Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel
NCT00743262Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
NCT04699292International Prospective Registry on Local Treatment Approaches in MLS
NCT04287829Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
NCT03482362Vinorelbine in Advanced BRAF-like Colon Cancer
NCT04871594Pre-operative Immunotherapy in Stage II-III Urothelial Cancer
NCT06514560OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
NCT01795976NY-ESO-1 T Cells in OG Cancer
NCT05529927Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
NCT04393376PSA Glycomics Assay for Early Detection of Prostate Cancer
NCT04287894Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment
NCT05162573EBRT + Lu-PSMA for N1M0 Prostate Cancer
NCT05120973Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.
NCT04022863Ovarium Cancer Detection by TEP's and ctDNA
NCT00783822Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients
NCT05401786Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC
NCT05079386Clinical Feasibility of a New Voice Prosthesis
NCT03448835Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)